[go: up one dir, main page]

FR2983731B1 - Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras - Google Patents

Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras

Info

Publication number
FR2983731B1
FR2983731B1 FR1161264A FR1161264A FR2983731B1 FR 2983731 B1 FR2983731 B1 FR 2983731B1 FR 1161264 A FR1161264 A FR 1161264A FR 1161264 A FR1161264 A FR 1161264A FR 2983731 B1 FR2983731 B1 FR 2983731B1
Authority
FR
France
Prior art keywords
fatty acid
local anesthetics
eutectic mixtures
emulsions based
topical emulsions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1161264A
Other languages
English (en)
Other versions
FR2983731A1 (fr
Inventor
Mathieu Lazerges
Philippe Espeau
Sylvie Sophie Crauste-Manciet
Denis Brossard
Yohann Corvis
Florence Agnely
Nicolas Huang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Paris Descartes
Original Assignee
Universite Paris Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Paris Descartes filed Critical Universite Paris Descartes
Priority to FR1161264A priority Critical patent/FR2983731B1/fr
Priority to CA 2858312 priority patent/CA2858312A1/fr
Priority to PCT/FR2012/052799 priority patent/WO2013083910A2/fr
Priority to EP12810341.3A priority patent/EP2787976A2/fr
Priority to US14/363,568 priority patent/US20150105426A1/en
Publication of FR2983731A1 publication Critical patent/FR2983731A1/fr
Application granted granted Critical
Publication of FR2983731B1 publication Critical patent/FR2983731B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne de nouvelles formulations pour l'anesthésie locale topique.
FR1161264A 2011-12-07 2011-12-07 Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras Expired - Fee Related FR2983731B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR1161264A FR2983731B1 (fr) 2011-12-07 2011-12-07 Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras
CA 2858312 CA2858312A1 (fr) 2011-12-07 2012-12-04 Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras en tant qu'analgesique, antalgique ou en tant que retardant sexuel
PCT/FR2012/052799 WO2013083910A2 (fr) 2011-12-07 2012-12-04 Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras en tant qu'analgesique, antalgique ou en tant que retardant sexuel
EP12810341.3A EP2787976A2 (fr) 2011-12-07 2012-12-04 Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras en tant qu'analgesique, antalgique ou en tant que retardant sexuel
US14/363,568 US20150105426A1 (en) 2011-12-07 2012-12-04 Topical emulsions based on mixtures of local eutectic anaesthetics and fatty acids as analgesics, antalgics, or as sexual retardants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1161264A FR2983731B1 (fr) 2011-12-07 2011-12-07 Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras

Publications (2)

Publication Number Publication Date
FR2983731A1 FR2983731A1 (fr) 2013-06-14
FR2983731B1 true FR2983731B1 (fr) 2014-04-25

Family

ID=47505206

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1161264A Expired - Fee Related FR2983731B1 (fr) 2011-12-07 2011-12-07 Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras

Country Status (5)

Country Link
US (1) US20150105426A1 (fr)
EP (1) EP2787976A2 (fr)
CA (1) CA2858312A1 (fr)
FR (1) FR2983731B1 (fr)
WO (1) WO2013083910A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3057771A1 (fr) * 2016-10-26 2018-04-27 Institut National De La Sante Et De La Recherche Medicale (Inserm) Emulsions topiques de lidocaine et d'acides gras utiles en tant qu'analgesique, antalgique ou retardant sexuel
KR102422382B1 (ko) * 2016-12-26 2023-01-25 셀릭스 바이오 프라이빗 리미티드 통증 치료를 위한 조성물
RU2019131370A (ru) * 2017-03-06 2021-04-07 Маруиси Фармасьютикал Ко., Лтд. Кислая эмульсионная композиция, содержащая местный анестетик
GB201913456D0 (en) * 2019-09-18 2019-10-30 Queens Univ Of Belfast Polymer-comprising medical devices and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition
ATE214599T1 (de) * 1996-10-14 2002-04-15 Kowa Co Lokalanästhetikum zur aüsserlichen anwendung
US7476400B2 (en) * 2001-11-13 2009-01-13 Ferndale Ip, Inc. High-concentration lidocaine compositions and methods for their preparation
AU2003212962A1 (en) * 2002-02-07 2003-09-02 Massachusetts Institute Of Technology Transdermal drug delivery systems
US20040109893A1 (en) * 2002-06-25 2004-06-10 Guohua Chen Sustained release dosage forms of anesthetics for pain management
AU2003289163A1 (en) * 2002-12-06 2004-06-30 Otsuka Pharmaceutical Factory, Inc. Propofol-containing fat emulsions
EP1663148A2 (fr) * 2003-08-25 2006-06-07 Foamix Ltd. Mousse pharmaceutique de penetration
US20080175810A1 (en) * 2007-01-22 2008-07-24 Jerry Zhang Topical compositions for cosmetic and pharmaceutical use
AU2011239636A1 (en) * 2010-04-13 2012-11-22 Najib Babul Dermal pharmaceutical compositions of 1-Methyl-2',6'-pipecoloxylidide and method of use
US8293288B2 (en) * 2011-02-23 2012-10-23 Edna Ma Pain relieving composition
JP5855349B2 (ja) * 2011-03-31 2016-02-09 小林製薬株式会社 油性製剤
WO2012151196A1 (fr) * 2011-05-03 2012-11-08 Orthocon, Inc. Compositions d'administration de médicament et procédés d'utilisation

Also Published As

Publication number Publication date
US20150105426A1 (en) 2015-04-16
WO2013083910A2 (fr) 2013-06-13
CA2858312A1 (fr) 2013-06-13
EP2787976A2 (fr) 2014-10-15
WO2013083910A3 (fr) 2013-10-24
FR2983731A1 (fr) 2013-06-14

Similar Documents

Publication Publication Date Title
JOP20180103A1 (ar) مركب صيدلاني
EP2773662A4 (fr) Formulations d'anticorps
EP2637690A4 (fr) FORMULATION LIQUIDE D'ANTICORPS ANTI-TNFalpha HAUTEMENT CONCENTRÉE AMÉLIORÉE
EP2664328A4 (fr) Préparation à base de composés d'acide gras omega3
AR094204A1 (es) Composiciones para el cuidado oral que contienen haluros de acido amino
EP2934505A4 (fr) Formulations d'acide eicosapentaénoïque (epa)
EP2903939A4 (fr) Compositions d'acide carboxylique stables et utilisations de celles-ci
EP2552216A4 (fr) Dérivés d'acide 1-amino-2-cyclopropyléthylboronique
EP2714009A4 (fr) Formulation liquide stable d'étanercept
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
MX377553B (es) Composicion farmaceutica estable y metodos de uso de la misma.
EP2931313A4 (fr) Formulations en solution d'anticorps anti-il-23p19 modifiés
EP2747832A4 (fr) Formulations d'agents actifs pour une libération prolongée
EP2827868A4 (fr) Compositions pharmaceutiques comprenant des esters d'acides gras
CR20140554A (es) Compuestos de acido dimetil-benzoico
BR112013030605A2 (pt) formulações orais de antioxidantes direcionados mitocondrialmente e preparação e uso dos mesmos
FR2981572B1 (fr) Compositions pharmaceutiques d'acide ursodesoxycholique
BR112014000077A2 (pt) formulação à base de leite
BR112013003216A2 (pt) composições sintéticas de ácido biliar e métodos
EP2557919A4 (fr) Formulations stabilisées de statine
UY33490A (es) Ésteres de quinolina nuevos útiles para el tratamiento de trastornos cutáneos.
EP2580342A4 (fr) Compositions comprenant de l'acide éicosapentaénoïque utilisées pour des purifications fortes
FR2983731B1 (fr) Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras
EP2854888A4 (fr) Compositions d'acide lipoïque utilisables comme agents antimicrobiens
FR2993781B1 (fr) Composition d'un sucrose-octasulfate et d'un emollient

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20200905